Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2017-10-05 M&A Activity
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
SLUTGILTIGT RESULTAT AV OFFENTLIGT UPPKÖPSERBJUDANDE AV WEIFA ASA
M&A Activity Classification · 99% confidence The document is titled "SLUTGILTIGT RESULTAT AV OFFENTLIGT UPPKÖPSERBJUDANDE AV WEIFA ASA" (Final Result of the Public Takeover Bid for Weifa ASA). It details the acceptance rate (97.23%), the expected settlement date, and the intention to initiate compulsory redemption and delisting because the threshold of over 90% ownership was achieved. This content directly relates to a merger or takeover activity, specifically the finalization of a public tender offer. This aligns perfectly with the definition for M&A Activity (Code: TAR). The document is a formal announcement regarding the outcome of a takeover bid.
2017-10-05 Swedish
FINAL RESULT OF THE VOLUNTARY OFFER FOR WEIFA ASA
M&A Activity Classification · 98% confidence The document announces the 'FINAL RESULT OF THE VOLUNTARY OFFER FOR WEIFA ASA' by Karo Pharma. It details the acceptance level (97.23%), expected settlement dates, and the intention to initiate a compulsory acquisition followed by a proposal for delisting from Oslo Børs. This content directly relates to a takeover bid or merger proposal, which aligns with the definition of M&A Activity (TAR). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific announcement about a transaction involving acquisition/takeover.
2017-10-05 English
TIDEN FÖR UPPKÖPS ERBJUDANDE AV WEIFA ASA UTGÅTT – UPPKÖP FRAMGÅNGSRIKT MED ACCEPTANS FRÅN 97,1 % AV AKTIEÄGARNA
M&A Activity Classification · 98% confidence The document text is a press release announcing the successful completion of a public takeover offer (uppköps erbjudande) by Karo Pharma for Weifa ASA, noting that the acceptance condition (97.1% acceptance) has been met. It discusses the next steps, including payment and subsequent compulsory redemption and delisting. This type of announcement, detailing a significant corporate transaction like a takeover or merger proposal, directly aligns with the definition for M&A Activity (TAR). It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a simple Report Publication Announcement (RPA), as it contains substantive details about the transaction's outcome rather than just announcing a report's availability. The content is focused entirely on the takeover bid's conclusion.
2017-10-03 Swedish
EXPIRATION OF VOLUNTARY OFFER PERIOD FOR WEIFA ASA – ACQUISITION SUCCESSFUL WITH ACCEPTANCES AT +97,1 %
M&A Activity Classification · 98% confidence The document is a stock exchange notice from Karo Pharma regarding the successful expiration of a voluntary offer to acquire shares in Weifa ASA. It details the acceptance rate (97.1%), confirms conditions are met, and states the intention to initiate a compulsory acquisition and propose a delisting. This content directly relates to a takeover bid or merger proposal. Therefore, it fits the definition of M&A Activity (TAR). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific corporate transaction.
2017-10-03 English
UPDATE ON VOLUNTARY OFFER FOR ACQUISITION OF WEIFA ASA – ACCEPTANCES AT +90,3%
M&A Activity Classification · 98% confidence The document is a short update (3690 chars) regarding a 'Voluntary Offer for Acquisition' of Weifa ASA by Karo Pharma. It announces that the acceptance condition (+90.3%) has been met and provides the deadline for remaining acceptances. Crucially, it mentions the intent to initiate a compulsory acquisition and propose a delisting. This type of announcement, detailing a takeover bid status and subsequent actions (like delisting proposal), falls under Merger & Acquisition (M&A) activity. The definition for M&A Activity (TAR) covers 'Announcements and documents related to merger proposals or takeover bids.' Since this is a brief announcement about the status of an ongoing takeover bid, TAR is the most appropriate classification, rather than the fallback (RNS) or a general regulatory filing (RPA), as the subject matter is highly specific to M&A.
2017-09-28 English
UPPDATERING AV OFFENTLIGT UPPKÖPSERBJUDANDE AV WEIFA ASA – ACCEPTANS AV BUDET FRÅN 90,3% AV AKTIEÄGARNA
M&A Activity Classification · 98% confidence The document is a press release dated September 28, 2017, titled "UPPDATERING AV OFFENTLIGT UPPKÖPSERBJUDANDE AV WEIFA ASA – ACCEPTANS AV BUDET FRÅN 90,3% AV AKTIEÄGARNA" (Update on the Public Takeover Bid for Weifa ASA – Acceptance of the Bid from 90.3% of Shareholders). It discusses the acceptance level of a takeover bid by Karo Pharma, the fulfillment of conditions, the upcoming expiration of the offer period, and plans for delisting. This content directly relates to a merger or takeover proposal. Therefore, the most appropriate classification is M&A Activity (TAR). It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it specifically details a transaction in the 'TAR' category.
2017-09-28 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.